Patents by Inventor Jason Boer

Jason Boer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DERIVATIVES OF AN FGFR INHIBITOR
    Publication number: 20220411423
    Abstract: The present disclosure relates to derivatives (e.g., hydroxyl, keto, glucuronide, sulfonic acid, and deuterated) of a Fibroblast Growth Factor Receptors (FGFR) inhibitor, including methods of preparation thereof, and intermediates in the preparation thereof, which are useful in the treatment of FGFR mediated disease such as cancer.
    Type: Application
    Filed: July 22, 2022
    Publication date: December 29, 2022
    Inventors: Ming Tao, Jason Boer
  • Derivatives of an FGFR inhibitor
    Patent number: 11407750
    Abstract: The present disclosure relates to derivatives (e.g., hydroxyl, keto, glucuronide, sulfonic acid, and deuterated) of a Fibroblast Growth Factor Receptors (FGFR) inhibitor, including methods of preparation thereof, and intermediates in the preparation thereof, which are useful in the treatment of FGFR mediated disease such as cancer.
    Type: Grant
    Filed: December 3, 2020
    Date of Patent: August 9, 2022
    Assignee: Incyte Corporation
    Inventors: Ming Tao, Jason Boer
  • DERIVATIVES OF AN FGFR INHIBITOR
    Publication number: 20210171522
    Abstract: The present disclosure relates to derivatives (e.g., hydroxyl, keto, glucuronide, sulfonic acid, and deuterated) of a Fibroblast Growth Factor Receptors (FGFR) inhibitor, including methods of preparation thereof, and intermediates in the preparation thereof, which are useful in the treatment of FGFR mediated disease such as cancer.
    Type: Application
    Filed: December 3, 2020
    Publication date: June 10, 2021
    Inventors: Ming Tao, Jason Boer